Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM OTEX
FY Jun 2026
$5.2B
FY Jun 2025
$5.2B
FY Jun 2024
$5.8B
FY Jun 2023
$4.5B
FY Jun 2022
$3.5B
Jun 2026
$1.3B
Mar 2026
$1.3B
Dec 2025
$1.3B
Sep 2025
$1.3B
Jun 2025
$1.3B
Mar 2025
$1.3B
Dec 2024
$1.3B
Sep 2024
$1.3B
At each fiscal year end
Single quarter
Net margin, TTM
+12.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM OTEX
FY Jun 2026
+12.3%
FY Jun 2025
+8.4%
FY Jun 2024
+8.1%
FY Jun 2023
+3.4%
FY Jun 2022
+11.4%
Jun 2026
+11.5%
Mar 2026
+13.5%
Dec 2025
+12.7%
Sep 2025
+11.4%
Jun 2025
+2.2%
Mar 2025
+7.4%
Dec 2024
+17.2%
Sep 2024
+6.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
$807.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM OTEX
FY Jun 2026
$807.5M
FY Jun 2025
$687.4M
FY Jun 2024
$808.4M
FY Jun 2023
$655.4M
FY Jun 2022
$888.7M
Jun 2026
$122.0M
Mar 2026
$304.9M
Dec 2025
$279.4M
Sep 2025
$101.2M
Jun 2025
$124.0M
Mar 2025
$373.8M
Dec 2024
$306.7M
Sep 2024
-$117.1M
At each fiscal year end
Single quarter
Debt to equity
1.44x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity OTEX
FY Jun 2026
1.44x
FY Jun 2025
1.62x
FY Jun 2024
1.52x
FY Jun 2023
2.21x
FY Jun 2022
1.05x
Jun 2026
1.44x
Mar 2026
1.57x
Dec 2025
1.58x
Sep 2025
1.61x
Jun 2025
1.62x
Mar 2025
1.55x
Dec 2024
1.51x
Sep 2024
1.55x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.17x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt OTEX
FY Jun 2026
0.17x
FY Jun 2025
0.13x
FY Jun 2024
0.15x
FY Jun 2023
0.09x
FY Jun 2022
0.23x
Jun 2026
0.17x
Mar 2026
0.16x
Dec 2025
0.16x
Sep 2025
0.17x
Jun 2025
0.13x
Mar 2025
0.13x
Dec 2024
0.13x
Sep 2024
0.13x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+16.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity OTEX
FY Jun 2026
+16.2%
FY Jun 2025
+10.7%
FY Jun 2024
+11.3%
FY Jun 2023
+3.7%
FY Jun 2022
+9.8%
Jun 2026
+16.2%
Mar 2026
+12.8%
Dec 2025
+10.5%
Sep 2025
+12.3%
Jun 2025
+10.7%
Mar 2025
+15.9%
Dec 2024
+16.0%
Sep 2024
+11.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets OTEX
FY Jun 2026
+4.8%
FY Jun 2025
+3.1%
FY Jun 2024
+3.0%
FY Jun 2023
+1.1%
FY Jun 2022
+4.0%
Jun 2026
+4.8%
Mar 2026
+3.8%
Dec 2025
+3.2%
Sep 2025
+3.7%
Jun 2025
+3.1%
Mar 2025
+4.3%
Dec 2024
+4.4%
Sep 2024
+3.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+9.3%
operating income after a 25.1% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital OTEX
FY Jun 2026
+9.3%
FY Jun 2025
+8.8%
FY Jun 2024
+6.1%
FY Jun 2023
+3.1%
FY Jun 2022
+7.5%
Jun 2026
+9.3%
Mar 2026
+8.8%
Dec 2025
+8.6%
Sep 2025
+8.7%
Jun 2025
+8.8%
Mar 2025
+6.6%
Dec 2024
+6.7%
Sep 2024
+6.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+10.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed OTEX
FY Jun 2026
+10.1%
FY Jun 2025
+8.0%
FY Jun 2024
+7.0%
FY Jun 2023
+4.6%
FY Jun 2022
+7.6%
Jun 2026
+10.1%
Mar 2026
+8.6%
Dec 2025
+8.5%
Sep 2025
+8.6%
Jun 2025
+8.0%
Mar 2025
+7.3%
Dec 2024
+7.4%
Sep 2024
+7.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
no close on file at or before the as-of date
P/E, trailing OTEX
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no close on file at or before the as-of date
Enterprise value OTEX
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no close on file at or before the as-of date
FCF yield OTEX
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
no close on file at or before the as-of date
PEG, trailing OTEX
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
OTEX ranks highest on institutional and government (64th percentile) and profitability (63rd), and lowest on financial health (27th), among Software & IT peers.
Profitability
63
Inputs
Return on equity+16.2% · 75 pct, sector of 286
Return on assets+4.8% · 70 pct, sector of 381
Return on invested capital+9.3% · 35 pct, sector of 78
Return on capital employed+10.1% · 73 pct, sector of 294
Financial health
27
Inputs
Debt to equity1.44x · 13 pct, sector of 288
Cash flow to debt0.17x · 41 pct, sector of 241
Growth
35
Inputs
Revenue growth, YoY+1.5% · 33 pct, sector of 480
Backlog growth, YoY+4.0% · 38 pct, sector of 182
Institutional and government
64
Inputs
Funds adding, latest quarter158 · 64 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
47
Inputs
Short interest, % of float+4.0% · 57 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.7% · 38 pct, sector of 316
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
OTEX filings, in plain words
Are there planned insider sales of OTEX?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $96.1K of stock; the latest, by PAUL DUGGAN, was filed 2026-09-14.
Read the full summary
Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $96.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.